254 related articles for article (PubMed ID: 20740675)
1. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
[TBL] [Abstract][Full Text] [Related]
2. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices.
Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E
Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006
[TBL] [Abstract][Full Text] [Related]
3. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
5. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
Czarnobaj K; Prokopowicz M; Sawicki W
AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
7. Study of mesoporous silica/magnetite systems in drug controlled release.
Souza KC; Ardisson JD; Sousa EM
J Mater Sci Mater Med; 2009 Feb; 20(2):507-12. PubMed ID: 18839283
[TBL] [Abstract][Full Text] [Related]
8. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
10. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
11. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system.
Medda L; Casula MF; Monduzzi M; Salis A
Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387
[TBL] [Abstract][Full Text] [Related]
12. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
13. A stand-alone mesoporous crystal structure model from in situ X-ray diffraction: nitrogen adsorption on 3D cagelike mesoporous silica SBA-16.
Miyasaka K; Hano H; Kubota Y; Lin Y; Ryoo R; Takata M; Kitagawa S; Neimark AV; Terasaki O
Chemistry; 2012 Aug; 18(33):10300-11. PubMed ID: 22829334
[TBL] [Abstract][Full Text] [Related]
14. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
15. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
[TBL] [Abstract][Full Text] [Related]
16. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
17. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
18. L-Trp adsorption into silica mesoporous materials to promote bone formation.
Balas F; Manzano M; Colilla M; Vallet-Regí M
Acta Biomater; 2008 May; 4(3):514-22. PubMed ID: 18234569
[TBL] [Abstract][Full Text] [Related]
19. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method.
Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
Sousa A; Souza KC; Sousa EM
Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
